Hello I'm Raiyyan Tahsan
Brand Model and Executive

TC(1352).(05).Orthopedic Case No 174. Traumatic Penetrating Soft-Tissue Injury with Foreign Body Impaction (Rust-Contaminated Material). (Prescription 1)3355

Prescription attached:-

đŸŠē COMPLETE PRESCRIPTION ANALYSIS & FINAL CLINICAL WORKING ASSESSMENT

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻĒā§‚āĻ°ā§āĻŖāĻžāĻ™ā§āĻ— āĻŦāĻŋāĻļā§āϞ⧇āώāĻŖ, āϏāĻ āĻŋāĻ• āĻ“āώ⧁āϧ āĻļāύāĻžāĻ•ā§āϤāĻ•āϰāĻŖ, āϰ⧋āĻ—āύāĻŋāĻ°ā§āϪ⧟ āĻāĻŦāĻ‚ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻĒāϰāĻŋāĻ•āĻ˛ā§āĻĒāύāĻž

Author: Md. Rafiqul Islam Lipu

Date: Tuesday, 13 October 2026

Time: 8:47 PM (Bangladesh Standard Time)

Clinical References: Bailey & Love, Harrison’s Internal Medicine, CDC, WSES, AAFP āĻāĻŦāĻ‚ MedEx BangladeshāĨ¤

Prescription Source: āωāĻĒāĻœā§‡āϞāĻž āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ āĻ•āĻŽāĻĒā§āϞ⧇āĻ•ā§āϏ, āĻŽāĻĻāύ, āύ⧇āĻ¤ā§āϰāϕ⧋āύāĻžāĨ¤

āϏāĻ‚āĻļā§‹āϧāĻŋāϤ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āϤāĻĨā§āϝ

āφāĻĒāύāĻžāϰ āĻĻ⧇āĻ“ā§ŸāĻž āϏāĻ‚āĻļā§‹āϧāύ āĻ…āύ⧁āϏāĻžāϰ⧇ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύāϟāĻŋ āύāϤ⧁āύ āĻ•āϰ⧇ āĻŦāĻŋāĻļā§āϞ⧇āώāĻŖ āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤

āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇:

  • Tab. Solivo 500 mg: āĻāϟāĻŋ āĻļ⧁āϧ⧁ Naproxen 500 mg āύ⧟; MedEx āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻāϰ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ composition āĻšāϞ⧋ Naproxen Sodium 500 mg + Esomeprazole Magnesium 20 mgāĨ¤
  • Viodin Wash: āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• Debridement āĻ“ wound care-āĻāϰ āϜāĻ¨ā§āϝ Viodin wash āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰ⧇āϛ⧇āύāĨ¤ āĻāϟāĻŋ Povidone Iodine-āĻāϰ āĻāĻ•āϟāĻŋ brand; Betadine āύ⧟āĨ¤
  • Inj. Vaxitet + IG: āĻāĻ–āĻžāύ⧇ āϟāĻŋāĻŸā§‡āύāĻžāϏ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇ vaccine āĻāĻŦāĻ‚ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ immunoglobulin/antitoxin āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āύāĻŋāĻ°ā§āĻĻ⧇āĻļ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

Clinical limitation: āĻāϟāĻŋ āϏāĻŽā§āĻ­āĻŦāϤ ā§§ā§§ āĻ…āĻ•ā§āĻŸā§‹āĻŦāϰ ⧍ā§Ļā§¨ā§Š āϏāĻžāϞ⧇āϰ āĻāĻ•āϟāĻŋ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύāĨ¤ āϰ⧋āĻ—ā§€āϰ āĻŦāĻ°ā§āϤāĻŽāĻžāύ āĻ…āĻŦāĻ¸ā§āĻĨāĻž, āĻ•ā§āώāϤ⧇āϰ āĻ¸ā§āĻĨāĻžāύ, āĻļāĻžāϰ⧀āϰāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻĢāϞāĻžāĻĢāϞ āĻāĻŦāĻ‚ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āϏāĻŽā§āĻĒāĻ¨ā§āύ āĻšā§Ÿā§‡āϛ⧇ āĻ•āĻŋ āύāĻž āϜāĻžāύāĻž āύ⧇āχāĨ¤ āϤāĻžāχ āύāĻŋāĻšā§‡āϰ āϰ⧋āĻ—āύāĻŋāĻ°ā§āϪ⧟āϟāĻŋ āĻĒ⧁āϰ⧋āύ⧋ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύāĻ­āĻŋāĻ¤ā§āϤāĻŋāĻ• clinical working assessment, āύāϤ⧁āύ āĻļāĻžāϰ⧀āϰāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ āύ⧟āĨ¤


1. Patient Information — āϰ⧋āĻ—ā§€āϰ āϤāĻĨā§āϝ

Parameter Findings
Healthcare Facility Upazila Health Complex, Madan, Netrokona
Department Emergency Department
Patient’s Age āφāύ⧁āĻŽāĻžāύāĻŋāĻ• ā§Šā§Ē āĻŦāĻ›āϰ
Prescription Date āϏāĻŽā§āĻ­āĻŦāϤ 11 October 2023
Presenting Problem Accidental Impaction of Rusty Materials
Doctor’s Diagnosis Foreign Body (FB) Impaction
Treatment Approach Foreign Body Removal, Wound Management āĻāĻŦāĻ‚ Tetanus Prophylaxis

Clinical Interpretation:

āϰ⧋āĻ—ā§€āϰ āĻļāϰ⧀āϰ⧇āϰ āϕ⧋āύ⧋ āĻāĻ•āϟāĻŋ āĻ…āĻ‚āĻļ⧇ āĻĻ⧁āĻ°ā§āϘāϟāύāĻžāĻŦāĻļāϤ āĻŽāϰāĻŋāϚāĻžāϝ⧁āĻ•ā§āϤ āĻŦāĻ¸ā§āϤ⧁ āĻĒā§āϰāĻŦ⧇āĻļ āĻ•āϰ⧇āϛ⧇ āĻŦāϞ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰ⧇āϛ⧇āύāĨ¤

āĻāχ āĻĒāϰāĻŋāĻ¸ā§āĻĨāĻŋāϤāĻŋāϤ⧇ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϏāĻŽāĻ¸ā§āϝāĻž āĻšāϞ⧋ Penetrating Soft-Tissue Injury with Foreign Body ImpactionāĨ¤


2. C/C — Chief Complaints

āϰ⧋āĻ—ā§€āϰ āĻĒā§āϰāϧāĻžāύ āĻ…āĻ­āĻŋāϝ⧋āĻ—

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇:

H/O Accidental Impaction of Rusty Materials

āĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨ: āĻĻ⧁āĻ°ā§āϘāϟāύāĻžāĻŦāĻļāϤ āĻŽāϰāĻŋāϚāĻžāϝ⧁āĻ•ā§āϤ āϕ⧋āύ⧋ āĻŦāĻ¸ā§āϤ⧁ āĻļāϰ⧀āϰ⧇āϰ āϟāĻŋāĻ¸ā§āϝ⧁āϤ⧇ āĻĒā§āϰāĻŦ⧇āĻļ āĻ•āϰāĻžāϰ āχāϤāĻŋāĻšāĻžāϏāĨ¤

āĻāĻ–āĻžāύ⧇:

H/O = History Of — āϰ⧋āĻ—ā§€āϰ āϘāϟāύāĻžāϰ āχāϤāĻŋāĻšāĻžāϏāĨ¤

Accidental = āĻĻ⧁āĻ°ā§āϘāϟāύāĻžāϜāύāĻŋāϤāĨ¤

Impaction = āϕ⧋āύ⧋ āĻŦāĻ¸ā§āϤ⧁ āφāϟāϕ⧇ āϝāĻžāĻ“ā§ŸāĻžāĨ¤

Rusty Materials = āĻŽāϰāĻŋāϚāĻžāϝ⧁āĻ•ā§āϤ āĻŦāĻ¸ā§āϤ⧁āĨ¤

Clinical Interpretation

āĻāχ āχāϤāĻŋāĻšāĻžāϏ Penetrating Injury āĻ“ Foreign Body Impaction-āĻāϰ āϏāĻ™ā§āϗ⧇ āϏāĻžāĻŽāĻžā§āϜāĻ¸ā§āϝāĻĒā§‚āĻ°ā§āĻŖāĨ¤

āϤāĻŦ⧇ āĻŦā§āϝāĻĨāĻž, āϰāĻ•ā§āϤāĻĒāĻžāϤ, āĻĢā§‹āϞāĻž, āĻœā§āĻŦāϰ āĻ…āĻĨāĻŦāĻž āĻĒ⧁āρāϜ āĻšāĻ“ā§ŸāĻžāϰ āĻ•āĻĨāĻž āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āĻ¸ā§āĻĒāĻˇā§āϟāĻ­āĻžāĻŦ⧇ āϞ⧇āĻ–āĻž āύ⧇āχāĨ¤

Confidence: 0.95


3. Patient History — āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰāĻž āχāϤāĻŋāĻšāĻžāϏ

History Prescription Findings
History of Trauma Present
Accidental Injury Present
Rusty Material Exposure Present
Foreign Body Impaction Mentioned
Previous Tetanus Vaccination Not mentioned
Diabetes Mellitus Not mentioned
Hypertension Not mentioned
Drug Allergy Not mentioned
Previous Surgery Not mentioned
Duration Since Injury Not mentioned

My Clinical Observation

āĻāχ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻ•ā§Ÿā§‡āĻ•āϟāĻŋ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ History āĻ…āύ⧁āĻĒāĻ¸ā§āĻĨāĻŋāϤ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āĻŦāĻŋāĻļ⧇āώāϤ:

  1. Site of Injury: āĻļāϰ⧀āϰ⧇āϰ āϕ⧋āύ āϜāĻžā§ŸāĻ—āĻžā§Ÿ āφāϘāĻžāϤ āϞ⧇āϗ⧇āϛ⧇?
  2. Time Since Injury: āĻ•āϤāĻ•ā§āώāĻŖ āφāϗ⧇ āφāϘāĻžāϤ āϞ⧇āϗ⧇āϛ⧇?
  3. Nature of Foreign Body: āĻĒ⧇āϰ⧇āĻ•, āϞ⧋āĻšāĻž, āϤāĻžāϰ āύāĻžāĻ•āĻŋ āĻ…āĻ¨ā§āϝ āĻŦāĻ¸ā§āϤ⧁?
  4. Tetanus Vaccination History: āĻļ⧇āώ āϟāĻŋāĻ•āĻž āĻ•āĻ–āύ āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§Ÿā§‡āĻ›āĻŋāϞ?
  5. Past Medical History: āĻĄāĻžā§ŸāĻžāĻŦ⧇āϟāĻŋāϏ āĻ…āĻĨāĻŦāĻž āϰ⧋āĻ—āĻĒā§āϰāϤāĻŋāϰ⧋āϧāĻ•ā§āώāĻŽāϤāĻž āĻ•āĻŽ āĻĨāĻžāĻ•āĻžāϰ āχāϤāĻŋāĻšāĻžāϏ āĻ°ā§Ÿā§‡āϛ⧇ āĻ•āĻŋ?

āĻāϗ⧁āϞ⧋ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϰ āϏāĻŋāĻĻā§āϧāĻžāĻ¨ā§āϤāϕ⧇ āĻĒā§āϰāĻ­āĻžāĻŦāĻŋāϤ āĻ•āϰ⧇āĨ¤


4. O/E — On Examination

āĻļāĻžāϰ⧀āϰāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻžā§Ÿ āϕ⧀ āĻĒāĻžāĻ“ā§ŸāĻž āϗ⧇āϛ⧇?

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āφāϞāĻžāĻĻāĻž āĻ•āϰ⧇ O/E findings āϞ⧇āĻ–āĻž āύ⧇āχāĨ¤

Examination Status
Pulse Not documented
Blood Pressure Not documented
Temperature Not documented
Wound Location Not clearly documented
Wound Depth Not documented
Local Tenderness Not documented
Swelling Not documented
Pus Discharge Not documented
Neurovascular Examination Not documented

Recommended Clinical Examination

āĻ•ā§āώāϤ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰ⧇ āĻĻ⧇āĻ–āϤ⧇ āĻšāĻŦ⧇:

  • Foreign Body āĻĻ⧃āĻļā§āϝāĻŽāĻžāύ āĻŦāĻž āĻ¸ā§āĻĒāĻ°ā§āĻļ⧇ āĻŦā§‹āĻāĻž āϝāĻžāĻšā§āϛ⧇ āĻ•āĻŋ āύāĻžāĨ¤
  • āĻ¸ā§āĻĨāĻžāĻ¨ā§€ā§Ÿ tenderness, swelling āĻāĻŦāĻ‚ erythema āφāϛ⧇ āĻ•āĻŋ āύāĻžāĨ¤
  • āĻ•ā§āώāϤ āĻĨ⧇āϕ⧇ discharge āĻŦ⧇āϰ āĻšāĻšā§āϛ⧇ āĻ•āĻŋ āύāĻžāĨ¤
  • āφāĻļāĻĒāĻžāĻļ⧇āϰ nerve, tendon āĻ“ blood vessel āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻšā§Ÿā§‡āϛ⧇ āĻ•āĻŋ āύāĻžāĨ¤

Clinical Note: āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• Drainage āϞāĻŋāϖ⧇āϛ⧇āύ āĻŦāϞ⧇ āϰ⧋āĻ—ā§€āϰ abscess āĻ›āĻŋāĻ˛â€”āĻāĻŽāύ āϏāĻŋāĻĻā§āϧāĻžāĻ¨ā§āϤ āύ⧇āĻ“ā§ŸāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤


5. Doctor's Diagnosis — āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āϰ⧋āĻ—āύāĻŋāĻ°ā§āϪ⧟

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āϞ⧇āĻ–āĻž āĻ°ā§Ÿā§‡āϛ⧇:

FB Impaction

Full Form: Foreign Body Impaction.

āĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨ

āĻļāϰ⧀āϰ⧇āϰ āϟāĻŋāĻ¸ā§āϝ⧁āϰ āĻŽāĻ§ā§āϝ⧇ āĻŦāĻžāχāϰ⧇āϰ āϕ⧋āύ⧋ āĻŦāĻ¸ā§āϤ⧁ āĻĒā§āϰāĻŦ⧇āĻļ āĻ•āϰ⧇ āφāϟāϕ⧇ āϝāĻžāĻ“ā§ŸāĻžāĨ¤

Pathophysiology — āϰ⧋āϗ⧇āϰ āĻĒā§āϰāĻ•ā§āϰāĻŋ⧟āĻž

āϝāĻ–āύ āϕ⧋āύ⧋ āϧāĻžāϰāĻžāϞ⧋ āĻŦāĻ¸ā§āϤ⧁ āĻ¤ā§āĻŦāĻ• āϭ⧇āĻĻ āĻ•āϰ⧇ āϟāĻŋāĻ¸ā§āϝ⧁āϰ āĻŽāĻ§ā§āϝ⧇ āĻĒā§āϰāĻŦ⧇āĻļ āĻ•āϰ⧇, āϤāĻ–āύ āĻ¸ā§āĻĨāĻžāĻ¨ā§€ā§ŸāĻ­āĻžāĻŦ⧇ tissue disruption, bleeding āĻāĻŦāĻ‚ inflammatory response āϏ⧃āĻˇā§āϟāĻŋ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Foreign Body āϟāĻŋāĻ¸ā§āϝ⧁āϰ āĻŽāĻ§ā§āϝ⧇ āφāϟāϕ⧇ āĻĨāĻžāĻ•āϞ⧇:

  • Persistent inflammation āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • Local pain āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • Bacterial infection-āĻāϰ āĻā§āρāĻ•āĻŋ āĻŦāĻžā§œāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • Abscess āϤ⧈āϰāĻŋ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • āĻ—āĻ­ā§€āϰ āφāϘāĻžāϤ⧇ nerve āĻŦāĻž tendon injury āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻŦ⧇ āĻāϗ⧁āϞ⧋ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϜāϟāĻŋāϞāϤāĻž; āĻāχ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϏāĻŦāϗ⧁āϞ⧋ āωāĻĒāĻ¸ā§āĻĨāĻŋāϤ āĻ›āĻŋāϞ āĻŦāϞ⧇ āĻĒā§āϰāĻŽāĻžāĻŖ āύ⧇āχāĨ¤


6. Doctor's Advice — āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ Advice āĻ…āĻ‚āĻļ⧇ āϞ⧇āĻ–āĻž āĻ°ā§Ÿā§‡āϛ⧇:

1. Excision

āĻŦāĻžāĻ‚āϞāĻž: āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§Ÿ āϟāĻŋāĻ¸ā§āϝ⧁ āϕ⧇āĻŸā§‡ āĻ…āĻĒāϏāĻžāϰāĻŖ āĻ•āϰāĻžāϰ āĻĒā§āϰāĻ•ā§āϰāĻŋ⧟āĻžāĨ¤

āĻ•ā§āώāϤ⧇āϰ āĻ…āĻŦāĻ¸ā§āĻĨāĻžāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ foreign body āĻ…āĻĒāϏāĻžāϰāĻŖ āĻŦāĻž āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āϟāĻŋāĻ¸ā§āϝ⧁ āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ⧇āϰ āϜāĻ¨ā§āϝ surgical excision āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

2. Drainage

āĻŦāĻžāĻ‚āϞāĻž: āĻ•ā§āώāϤ⧇ āϜāĻŽā§‡ āĻĨāĻžāĻ•āĻž āϤāϰāϞ āĻŦāĻž āĻĒ⧁āρāϜ āĻŦ⧇āϰ āĻ•āϰ⧇ āĻĻ⧇āĻ“ā§ŸāĻžāĨ¤

āϝāĻĻāĻŋ āĻ¸ā§āĻĨāĻžāĻ¨ā§€ā§Ÿ abscess āĻĨāĻžāϕ⧇, āϤāĻžāĻšāϞ⧇ incision and drainage āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻŦ⧇ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ abscess āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āĻšā§ŸāύāĻŋāĨ¤

3. Expulsion of FB

āĻŦāĻžāĻ‚āϞāĻž: āĻļāϰ⧀āϰ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āφāϟāϕ⧇ āĻĨāĻžāĻ•āĻž āĻŦāĻžāχāϰ⧇āϰ āĻŦāĻ¸ā§āϤ⧁ āĻŦ⧇āϰ āĻ•āϰāĻžāĨ¤

āĻāϟāĻŋ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻ…āĻ¨ā§āϝāϤāĻŽ āĻĒā§āϰāϧāĻžāύ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āωāĻĻā§āĻĻ⧇āĻļā§āϝāĨ¤

4. Debridement

āĻŦāĻžāĻ‚āϞāĻž: āĻ•ā§āώāϤ āĻĨ⧇āϕ⧇ āĻŽā§ƒāϤ, āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻ…āĻĨāĻŦāĻž āĻĻā§‚āώāĻŋāϤ āϟāĻŋāĻ¸ā§āϝ⧁ āĻ…āĻĒāϏāĻžāϰāĻŖ āĻ•āϰāĻžāĨ¤

5. Viodin Wash

āĻŦāĻžāĻ‚āϞāĻž: āĻ•ā§āώāϤāĻ¸ā§āĻĨāĻžāύ⧇āϰ antiseptic cleaning-āĻāϰ āϜāĻ¨ā§āϝ Viodin āĻŦā§āϝāĻŦāĻšāĻžāϰāĨ¤

āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻĒāĻžāĻ°ā§āĻĨāĻ•ā§āϝ: Debridement āĻāĻŦāĻ‚ Viodin wash āĻāĻ• āĻŦāĻŋāώ⧟ āύ⧟āĨ¤ Debridement āĻšāϞ⧋ devitalized tissue āĻ…āĻĒāϏāĻžāϰāĻŖ; Viodin āĻšāϞ⧋ antiseptic preparationāĨ¤

Deep wound-āĻāϰ irrigation-āĻāϰ āϜāĻ¨ā§āϝ normal saline āϏāĻžāϧāĻžāϰāĻŖāϤ āωāĻĒāϝ⧁āĻ•ā§āϤāĨ¤ āύāĻŋ⧟āĻŽāĻŋāϤ concentrated povidone-iodine āĻĻāĻŋā§Ÿā§‡ āĻ—āĻ­ā§€āϰ āĻ•ā§āώāϤ⧇āϰ āϭ⧇āϤāϰ irrigation āĻ•āϰāϞ⧇ tissue irritation āĻ“ healing impairment āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Advice Summary

Excision, Drainage, Foreign Body Removal, Debridement and Viodin Wash.

āĻāχ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāύāĻžāϗ⧁āϞ⧋ āϞ⧇āĻ–āĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤ āĻŦāĻžāĻ¸ā§āϤāĻŦ⧇ āĻĒā§āϰāϤāĻŋāϟāĻŋ procedure āϏāĻŽā§āĻĒāĻ¨ā§āύ āĻšā§Ÿā§‡āĻ›āĻŋāϞ āĻ•āĻŋ āύāĻž, āϤāĻž āύāĻŋāĻļā§āϚāĻŋāϤ āύ⧟āĨ¤


7. Prescribed Drug Analysis — MedEx āĻ…āύ⧁āϝāĻžā§Ÿā§€

āĻāχ āĻ…āĻ‚āĻļ⧇ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻ“āώ⧁āϧāϗ⧁āϞ⧋ Brand Name, Generic Name, MedEx Therapeutic Class, Pharmacological Class, Composition, Price, Indications āĻāĻŦāĻ‚ Patient-specific Purpose āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻŦāĻŋāĻļā§āϞ⧇āώāĻŖ āĻ•āϰāĻž āĻšāϞ⧋āĨ¤

Drug No. 1 — Inj. Vaxitet

Brand Name: Vaxitet

Generic Name: Adsorbed Tetanus Vaccine

Composition: 40 IU/0.5 ml

Manufacturer: Incepta Pharmaceuticals Ltd.

Dosage Form: Intramuscular Injection

MedEx Therapeutic Class

Vaccines, Anti-sera & Immunoglobulin

Pharmacological Class

Tetanus Toxoid Vaccine — Active Immunizing Agent

Price According to MedEx

Presentation Price
0.5 ml Ampoule ā§ŗ60.00
0.5 ml Vial ā§ŗ95.00
Pack of 10 Ampoules ā§ŗ600.00

MedEx Link: Vaxitet 40 IU/0.5 ml — MedEx

Use of Purpose the Drug

Vaxitet āĻšāϞ⧋ Tetanus āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇āϰ āϟāĻŋāĻ•āĻžāĨ¤

āĻāχ vaccine āĻļāϰ⧀āϰāϕ⧇ Clostridium tetani-āĻāϰ toxin-āĻāϰ āĻŦāĻŋāϰ⧁āĻĻā§āϧ⧇ protective antibody āϤ⧈āϰāĻŋ āĻ•āϰāϤ⧇ āωāĻĻā§āĻĻā§€āĻĒāĻŋāϤ āĻ•āϰ⧇āĨ¤

āϕ⧋āύ āϕ⧋āύ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻšā§Ÿ?

  1. Tetanus prevention following injury.
  2. Routine tetanus immunization.
  3. Tetanus booster vaccination.
  4. Appropriate immunization schedules during pregnancy.

Why Doctor Prescribed This Drug in This Patient

āϰ⧋āĻ—ā§€āϰ āĻĻ⧁āĻ°ā§āϘāϟāύāĻžāϜāύāĻŋāϤ penetrating injury āĻšā§Ÿā§‡āĻ›āĻŋāϞ āĻāĻŦāĻ‚ rusty material-āĻāϰ āχāϤāĻŋāĻšāĻžāϏ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

Puncture āĻŦāĻž penetrating wound āϟāĻŋāĻŸā§‡āύāĻžāϏ⧇āϰ āϜāĻ¨ā§āϝ high-risk wound category-āϤ⧇ āĻĒ⧜āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻžāχ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āϏāĻŽā§āĻ­āĻŦāϤ Post-exposure Tetanus Prophylaxis-āĻāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ Vaxitet āϞāĻŋāϖ⧇āϛ⧇āύāĨ¤

Confidence: 0.98

Clinical Note

āĻŽāϰāĻŋāϚāĻž āύāĻŋāĻœā§‡ āϟāĻŋāĻŸā§‡āύāĻžāϏ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰ⧇ āύāĻžāĨ¤

āϟāĻŋāĻŸā§‡āύāĻžāϏ āĻšā§Ÿ Clostridium tetani āύāĻžāĻŽāĻ• āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϰ toxin-āĻāϰ āĻ•āĻžāϰāϪ⧇āĨ¤

āϟāĻŋāĻ•āĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ•āĻŋ āύāĻž, āϤāĻž āĻ•ā§āώāϤ⧇āϰ āϧāϰāύ āĻ“ āĻĒā§‚āĻ°ā§āĻŦāĻŦāĻ°ā§āϤ⧀ vaccination history āĻ…āύ⧁āϝāĻžā§Ÿā§€ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāϤ⧇ āĻšā§ŸāĨ¤

CDC 2026 āĻ…āύ⧁āϝāĻžā§Ÿā§€ dirty wound-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ primary vaccine series āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āĻĨāĻžāĻ•āϞ⧇āĻ“ āĻļ⧇āώ tetanus vaccine āĻĒāĻžāρāϚ āĻŦāĻ›āϰ āĻŦāĻž āϤāĻžāϰ āĻŦ⧇āĻļāĻŋ āφāϗ⧇ āĻĻ⧇āĻ“ā§ŸāĻž āĻšāϞ⧇ booster āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤


Drug No. 2 — Tetanus IG

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ Vaxitet + IG āϞ⧇āĻ–āĻž āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āĻāĻ–āĻžāύ⧇ IG-āĻāϰ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ preparation āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āĻļāύāĻžāĻ•ā§āϤ āĻ•āϰāĻž āϝāĻžā§ŸāύāĻŋāĨ¤

āϤāĻžāχ Human Tetanus Immunoglobulin āĻāĻŦāĻ‚ Equine Tetanus Antitoxin āφāϞāĻžāĻĻāĻž āĻ•āϰ⧇ āĻŦ⧁āĻāϤ⧇ āĻšāĻŦ⧇āĨ¤

A. Human Tetanus Immunoglobulin

Generic Name: Human Tetanus Immunoglobulin

MedEx Therapeutic Class

Vaccines, Anti-sera & Immunoglobulin

Pharmacological Class

Passive Immunizing Agent

Bangladesh Available Brands

Brand Company Composition Price
Protet-IG Incepta 250 IU/ml ā§ŗ975
Tetagam-P CSL Behring 250 IU/ml ā§ŗ1,300

MedEx Link: Protet-IG — MedEx

Use of Purpose the Drug

Human TIG āϏāϰāĻžāϏāϰāĻŋ antibody āϏāϰāĻŦāϰāĻžāĻš āĻ•āϰ⧇ āϏāĻžāĻŽā§ŸāĻŋāĻ• passive protection āĻĻā§‡ā§ŸāĨ¤

Why Would the Doctor Prescribe This Drug?

āϰ⧋āĻ—ā§€āϰ tetanus vaccination history āĻ…āϜāĻžāύāĻž āĻ…āĻĨāĻŦāĻž āĻ…āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āĻĨāĻžāĻ•āϞ⧇ TIG āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

CDC Guideline — 2026

Dirty āĻŦāĻž penetrating wound-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ TIG āĻŦāĻŋāĻŦ⧇āĻšā§āϝ, āϝāĻĻāĻŋ āϰ⧋āĻ—ā§€āϰ:

  • Vaccination history unknown āĻĨāĻžāϕ⧇āĨ¤
  • Primary vaccination series incomplete āĻĨāĻžāϕ⧇āĨ¤
  • Previously unvaccinated āĻšāĻ“ā§ŸāĻžāϰ āχāϤāĻŋāĻšāĻžāϏ āĻĨāĻžāϕ⧇āĨ¤
  • HIV āĻ…āĻĨāĻŦāĻž severe immunodeficiency āĻĨāĻžāϕ⧇āĨ¤

Recommended Human TIG prophylactic dose, when indicated: 250 IU IM.

B. Vaxitet-IG — Equine Tetanus Antitoxin

āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ Vaxitet-IG āύāĻžāĻŽā§‡āϰ āφāϰ⧇āĻ•āϟāĻŋ preparation āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāĨ¤

Parameter Information
Brand Vaxitet-IG
Generic Tetanus Antitoxin (Equine)
Composition 3000 IU/ml
Manufacturer Incepta
Unit Price ā§ŗ408 per vial

MedEx Link: Vaxitet-IG — MedEx

Important Difference

Human TIG āĻāĻŦāĻ‚ Equine Tetanus Antitoxin āĻāĻ•āχ āĻ“āώ⧁āϧ āύ⧟āĨ¤

Equine antitoxin-āĻ hypersensitivity, anaphylaxis āĻ“ serum sickness-āĻāϰ āĻā§āρāĻ•āĻŋ āĻŦ⧇āĻļāĻŋāĨ¤

Human TIG āĻĒāĻžāĻ“ā§ŸāĻž āϗ⧇āϞ⧇ āϏ⧇āϟāĻŋāχ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻĒāĻ›āĻ¨ā§āĻĻāĻ¨ā§€ā§Ÿ passive immunizing preparationāĨ¤

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ IG āĻ…āĻ‚āĻļāϟāĻŋ āĻĻ⧇āϖ⧇ āϕ⧋āύ preparation āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āĻšā§Ÿā§‡āĻ›āĻŋāϞ, āϤāĻž āύāĻŋāĻļā§āϚāĻŋāϤ āĻŦāϞāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤

Identification Confidence: 0.50


Drug No. 3 — Cap. Polycef 500 mg

Brand Name

Polycef 500 mg

Generic Name

Cephradine 500 mg

Manufacturer

Renata PLC

MedEx Therapeutic Class

First Generation Cephalosporins

Pharmacological Class

First-generation Cephalosporin Antibiotic

Unit Price and Strip Price

Presentation Price
Unit Price ā§ŗ12.54
Strip Price (4 capsules) ā§ŗ50.16
Pack Price (28 capsules) ā§ŗ351.12

Other Available Compositions

Composition Dosage Form
250 mg Capsule
500 mg Capsule
125 mg/5 ml Suspension
250 mg/5 ml Suspension
125 mg/1.25 ml Pediatric Drops
500 mg/vial Injection
1 g/vial Injection

MedEx Link: Polycef 500 mg — MedEx

Mechanism of Action

Cephradine āĻāĻ•āϟāĻŋ beta-lactam antibioticāĨ¤

āĻāϟāĻŋ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϰ cell-wall synthesis āĻŦāĻžāϧāĻžāĻ—ā§āϰāĻ¸ā§āϤ āĻ•āϰ⧇āĨ¤

āĻĢāϞ⧇ āϏāĻ‚āĻŦ⧇āĻĻāύāĻļā§€āϞ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻž āĻ§ā§āĻŦāĻ‚āϏ āĻšā§ŸāĨ¤

Use of Purpose the Drug

Polycef āĻŽā§‚āϞāϤ susceptible bacterial infection-āĻāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžā§Ÿ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§ŸāĨ¤

āϕ⧋āύ āϕ⧋āύ āϰ⧋āϗ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻšā§Ÿ?

  1. Skin and Soft Tissue Infection: āĻ¤ā§āĻŦāĻ• āĻ“ āύāϰāĻŽ āϟāĻŋāĻ¸ā§āϝ⧁āϰ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤
  2. Cellulitis: āĻ¤ā§āĻŦāĻ• āĻ“ subcutaneous tissue-āĻāϰ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤
  3. Abscess: āωāĻĒāϝ⧁āĻ•ā§āϤ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻĒ⧁āρāϜāϝ⧁āĻ•ā§āϤ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ; drainage āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  4. Respiratory Tract Infection: āϏāĻ‚āĻŦ⧇āĻĻāύāĻļā§€āϞ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϜāύāĻŋāϤ āĻļā§āĻŦāĻžāϏāϤāĻ¨ā§āĻ¤ā§āϰ⧇āϰ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤
  5. Urinary Tract Infection: āϏāĻ‚āĻŦ⧇āĻĻāύāĻļā§€āϞ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋ⧟āĻžāϰ āĻ•āĻžāϰāϪ⧇ āĻŽā§‚āĻ¤ā§āϰāύāĻžāϞāĻŋāϰ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāĨ¤

Why Doctor Prescribed Polycef in This Patient

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āϏāĻŽā§āĻ­āĻŦāϤ contaminated wound-āĻāϰ bacterial infection āĻĒā§āϰāϤāĻŋāϰ⧋āϧ āĻ…āĻĨāĻŦāĻž āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ¸ā§āĻĨāĻžāĻ¨ā§€ā§Ÿ āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϰ āϜāĻ¨ā§āϝ Polycef āĻĻāĻŋā§Ÿā§‡āϛ⧇āύāĨ¤

āϤāĻŦ⧇ āϕ⧋āύ⧋ āĻ•ā§āώāϤ⧇ antibiotic āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ•āĻŋ āύāĻž, āϤāĻž āύāĻŋāĻ°ā§āĻ­āϰ āĻ•āϰ⧇:

  • āĻ•ā§āώāϤ⧇āϰ āĻ—āĻ­ā§€āϰāϤāĻžāϰ āĻ“āĻĒāϰāĨ¤
  • āĻ•ā§āώāϤ āĻ•āϤāϟāĻž contaminatedāĨ¤
  • Foreign Body āĻ…āĻŦāĻļāĻŋāĻˇā§āϟ āφāϛ⧇ āĻ•āĻŋ āύāĻžāĨ¤
  • Infection-āĻāϰ clinical evidenceāĨ¤
  • Patient risk factorsāĨ¤

Clinical Assessment: Polycef-āĻāϰ āĻŦā§āϝāĻŦāĻšāĻžāϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝāĻ­āĻžāĻŦ⧇ āϝ⧁āĻ•ā§āϤāĻŋāϏāĻ‚āĻ—āϤ, āĻ•āĻŋāĻ¨ā§āϤ⧁ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ confirmed bacterial infection-āĻāϰ āĻĒā§āϰāĻŽāĻžāĻŖ āύ⧇āχāĨ¤

Confidence in likely prescribing purpose: 0.85

Bangladesh Available Alternative Brands

Brand Company Generic
Lebac 500 Square Cephradine
Procef 500 Incepta Cephradine
Intracef 500 Beximco Cephradine
Polycef 500 Renata Cephradine
Rocef 500 Healthcare Cephradine

Precaution: Cephalosporin allergy āĻāĻŦāĻ‚ renal impairment āĻĨāĻžāĻ•āϞ⧇ āϏāϤāĻ°ā§āĻ•āϤāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤


Drug No. 4 — Tab. Solivo 500 mg

Corrected Medicine Identification

Brand Name: Solivo 500 mg + 20 mg

Generic Name: Naproxen Sodium + Esomeprazole Magnesium

Manufacturer: Healthcare Pharmaceuticals Ltd.

Dosage Form: Delayed Release Tablet

Correct Composition

Active Ingredient Strength
Naproxen Sodium 500 mg
Esomeprazole Magnesium 20 mg

āĻ…āĻ°ā§āĻĨāĻžā§Ž Solivo 500 āĻšāϞ⧋ āĻāĻ•āϟāĻŋ combination medicine; āĻļ⧁āϧ⧁ Naproxen 500 mg āύ⧟āĨ¤

MedEx Therapeutic Class

MedEx āĻ…āύ⧁āϝāĻžā§Ÿā§€:

Drugs for Osteoarthritis, Drugs used for Rheumatoid Arthritis, Non-steroidal Anti-inflammatory Drugs (NSAIDs).

Pharmacological Class

āĻĻ⧁āϟāĻŋ āωāĻĒāĻžāĻĻāĻžāύ⧇āϰ pharmacological class āφāϞāĻžāĻĻāĻžāĨ¤

1. Naproxen Sodium

  • Non-steroidal Anti-inflammatory Drug (NSAID)
  • Analgesic
  • Anti-inflammatory Agent
  • Antipyretic

2. Esomeprazole Magnesium

  • Proton Pump Inhibitor (PPI)
  • Gastric Acid Secretion Inhibitor

Price According to MedEx

Presentation Price
Unit Price ā§ŗ15.00
Strip Price (6 tablets) ā§ŗ90.00
Pack Price (30 tablets) ā§ŗ450.00

Other Available Composition

Solivo 375 mg + 20 mg

Unit Price: ā§ŗ13.00

MedEx Link: Solivo 500 mg + 20 mg — MedEx

Mechanism of Action

Naproxen: COX-mediated prostaglandin synthesis āĻ•āĻŽāĻŋā§Ÿā§‡ pain āĻ“ inflammation āωāĻĒāĻļāĻŽ āĻ•āϰ⧇āĨ¤

Esomeprazole: Gastric parietal cell-āĻāϰ proton pump inhibit āĻ•āϰ⧇ gastric acid secretion āĻ•āĻŽāĻžā§ŸāĨ¤

Use of Purpose the Drug

MedEx-āĻāϰ labelled indications āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻāϟāĻŋ āĻŽā§‚āϞāϤ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§Ÿ:

  1. Osteoarthritis — āĻ…āĻ¸ā§āĻĨāĻŋāϏāĻ¨ā§āϧāĻŋāϰ āĻ•ā§āώ⧟āϜāύāĻŋāϤ āĻŦā§āϝāĻĨāĻž āĻ“ āĻĒā§āϰāĻĻāĻžāĻšāĨ¤
  2. Rheumatoid Arthritis — āĻĒā§āϰāĻĻāĻžāĻšāϜāύāĻŋāϤ āĻŦāĻžāϤāĨ¤
  3. Ankylosing Spondylitis — āĻŽā§‡āϰ⧁āĻĻāĻŖā§āĻĄā§‡āϰ āĻĒā§āϰāĻĻāĻžāĻšāϜāύāĻŋāϤ āĻŦāĻžāϤāĨ¤
  4. NSAID-associated Gastric Ulcer Risk Reduction — NSAID-āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āĻĒāĻžāĻ•āĻ¸ā§āĻĨāϞ⧀āϰ āφāϞāϏāĻžāϰ⧇āϰ āĻā§āρāĻ•āĻŋ āĻ•āĻŽāĻžāύ⧋āĨ¤

Why Doctor Prescribed Solivo in This Patient

āĻāχ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϏāĻŽā§āĻ­āĻŦāϤ āφāϘāĻžāϤāϜāύāĻŋāϤ āĻŦā§āϝāĻĨāĻž āĻāĻŦāĻ‚ āĻ¸ā§āĻĨāĻžāĻ¨ā§€ā§Ÿ inflammation āĻ•āĻŽāĻžāύ⧋āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ Solivo āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤

Naproxen-āĻāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ: Injury-related pain āĻ“ inflammatory response āύāĻŋ⧟āĻ¨ā§āĻ¤ā§āϰāĻŖ āĻ•āϰāĻžāĨ¤

Esomeprazole-āĻāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ: Naproxen-āĻāϰ āĻ•āĻžāϰāϪ⧇ gastric acid-related complication āĻ“ ulcer-āĻāϰ āĻā§āρāĻ•āĻŋ āĻ•āĻŽāĻžāύ⧋āĨ¤

āĻāϟāĻŋ āϰ⧋āĻ—ā§€āϰ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ prescribing rationaleāĨ¤ āϤāĻŦ⧇ traumatic wound pain, Solivo combination-āĻāϰ āĻĒā§āϰāϧāĻžāύ labelled indication āύ⧟āĨ¤

Clinical Justification

Penetrating injury-āĻāϰ āĻĒāϰ⧇ āĻŦā§āϝāĻĨāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻžāχ analgesic āĻŦā§āϝāĻŦāĻšāĻžāϰ āϝ⧁āĻ•ā§āϤāĻŋāϝ⧁āĻ•ā§āϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻ•āĻŋāĻ¨ā§āϤ⧁ NSAID āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āφāϗ⧇ āϰ⧋āĻ—ā§€āϰ bleeding risk, renal function, peptic ulcer history, cardiovascular disease āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻ“āώ⧁āϧ āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Important Precautions

Solivo āĻŦā§āϝāĻŦāĻšāĻžāϰ āϏāϤāĻ°ā§āĻ•āϤāĻžāϰ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ:

  • Peptic Ulcer DiseaseāĨ¤
  • Gastrointestinal BleedingāĨ¤
  • Renal ImpairmentāĨ¤
  • NSAID HypersensitivityāĨ¤
  • Anticoagulant UseāĨ¤
  • Significant Cardiovascular DiseaseāĨ¤
  • Pregnancy, particularly third trimesterāĨ¤

Esomeprazole āĻĒāĻžāĻ•āĻ¸ā§āĻĨāϞ⧀āϰ āĻ•āĻŋāϛ⧁ āĻā§āρāĻ•āĻŋ āĻ•āĻŽāĻžāϞ⧇āĻ“ Naproxen-āĻāϰ kidney, cardiovascular āĻŦāĻž bleeding-related āϏāĻŦ āĻā§āρāĻ•āĻŋ āĻĻā§‚āϰ āĻ•āϰ⧇ āύāĻžāĨ¤

Clinical Confidence in prescribing purpose: 0.90

Bangladesh Alternative Brands — Same Composition

Brand Company Composition
Xenole Square 500 mg + 20 mg
Dinovo Beximco 500 mg + 20 mg
Progesic Incepta 500 mg + 20 mg
Progut-N Popular 500 mg + 20 mg
Solivo Healthcare 500 mg + 20 mg

āĻāχ brand-āϗ⧁āϞ⧋ āĻāĻ•āχ generic combination-āĻāϰ āωāĻĻāĻžāĻšāϰāĻŖāĨ¤ Prescribed brand āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ⧇āϰ āφāϗ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻ…āύ⧁āĻŽā§‹āĻĻāύ āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤


Drug No. 5 — Viodin Wash

Corrected Identification

Brand Name: Viodin

Generic Name: Povidone Iodine

Manufacturer: Square Pharmaceuticals PLC

Likely Preparation: Viodin 10% w/v Solution

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ concentration āĻ¸ā§āĻĒāĻˇā§āϟāĻ­āĻžāĻŦ⧇ āϞ⧇āĻ–āĻž āύ⧇āχāĨ¤ āϤāĻžāχ 10% Solution-āϕ⧇ āϏāĻŦāĻšā§‡ā§Ÿā§‡ āĻĒā§āϰāĻžāϏāĻ™ā§āĻ—āĻŋāĻ• marketed preparation āĻšāĻŋāϏ⧇āĻŦ⧇ āĻĻ⧇āĻ–āĻžāύ⧋ āĻšā§Ÿā§‡āϛ⧇āĨ¤

MedEx Therapeutic Class

Iodine Compounds (Anti-septic Preparations)

Pharmacological Class

Topical Antiseptic / Iodophor Antimicrobial Agent

Available Compositions

Preparation Strength
Viodin Solution 10% w/v
Viodin Ointment 5% w/w
Viodin Mouthwash 1% w/v

āĻāχ āϰ⧋āĻ—ā§€āϰ wound care-āĻāϰ āϜāĻ¨ā§āϝ Mouthwash āύ⧟, Solution formulation āĻĒā§āϰāĻžāϏāĻ™ā§āĻ—āĻŋāĻ•āĨ¤

Unit Price and Pack Price

Presentation Price
15 ml Solution ā§ŗ30
100 ml Solution ā§ŗ120
1000 ml Solution ā§ŗ800

MedEx Link: Viodin 10% Solution — MedEx

Mechanism of Action

Povidone Iodine āĻāĻ•āϟāĻŋ broad-spectrum antisepticāĨ¤

āĻāϟāĻŋ āϧ⧀āϰ⧇ āϧ⧀āϰ⧇ free iodine release āĻ•āϰ⧇ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āĻ…āϪ⧁āĻœā§€āĻŦ⧇āϰ protein āĻ“ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ cellular component āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻ•āϰ⧇āĨ¤

āĻāϟāĻŋ āĻ…āύ⧇āĻ• bacteria, fungi āĻ“ virus-āĻāϰ āĻŦāĻŋāϰ⧁āĻĻā§āϧ⧇ āĻ•āĻžāĻ°ā§āϝāĻ•āϰāĨ¤

Use of Purpose the Drug

Viodin-āĻāϰ āĻŦā§āϝāĻŦāĻšāĻžāϰāϗ⧁āϞ⧋āϰ āĻŽāĻ§ā§āϝ⧇ āĻ°ā§Ÿā§‡āϛ⧇:

  1. Wound Antisepsis: āĻ•ā§āώāϤāĻ¸ā§āĻĨāĻžāύ⧇ āĻœā§€āĻŦāĻžāϪ⧁āϰ āĻĒāϰāĻŋāĻŽāĻžāĻŖ āĻ•āĻŽāĻžāύ⧋āĨ¤
  2. Preoperative Skin Preparation: āĻ…āĻ¸ā§āĻ¤ā§āϰ⧋āĻĒāϚāĻžāϰ⧇āϰ āφāϗ⧇ āĻ¤ā§āĻŦāĻ• antisepsisāĨ¤
  3. Postoperative Wound Care: āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĻŽāϤ⧋ postoperative wound antisepsisāĨ¤
  4. Minor Cuts and Abrasions: āϛ⧋āϟ āĻ•āĻžāϟāĻž āĻŦāĻž āĻ›ā§œā§‡ āϝāĻžāĻ“ā§ŸāĻž āĻ•ā§āώāϤ⧇ topical antiseptic āĻšāĻŋāϏ⧇āĻŦ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰāĨ¤

Why Doctor Prescribed Viodin in This Patient

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• Debridement āĻāĻŦāĻ‚ Foreign Body Removal-āĻāϰ āϏāĻ™ā§āϗ⧇ wound antisepsis-āĻāϰ āϜāĻ¨ā§āϝ Viodin wash āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰ⧇āϛ⧇āύāĨ¤

āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āωāĻĻā§āĻĻ⧇āĻļā§āϝ:

  • āĻ•ā§āώāϤāĻ¸ā§āĻĨāĻžāύ⧇āϰ āφāĻļāĻĒāĻžāĻļ⧇ microbial contamination āĻ•āĻŽāĻžāύ⧋āĨ¤
  • Surgical wound preparationāĨ¤
  • Dressing-āĻāϰ āφāϗ⧇ āωāĻĒāϝ⧁āĻ•ā§āϤ topical antiseptic careāĨ¤

Is Viodin Suitable for Debridement?

Viodin āύāĻŋāĻœā§‡ Debridement āĻ•āϰ⧇ āύāĻžāĨ¤

Debridement-āĻ dead tissue āĻ“ foreign material āĻ…āĻĒāϏāĻžāϰāĻŖ āĻ•āϰāĻž āĻšā§ŸāĨ¤

Viodin wound antisepsis-āĻāϰ āϏāĻšāĻžā§ŸāĻ• āωāĻĒāĻžāĻĻāĻžāύāĨ¤

AAFP-āĻāϰ evidence review āĻ…āύ⧁āϝāĻžā§Ÿā§€ foreign-body wound āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ⧇ normal saline āĻŦāĻž potable water āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝāĻžā§Ÿ, āĻāĻŦāĻ‚ deep wound irrigation-āĻ antiseptic solution āϏāĻžāϧāĻžāϰāĻŖāϤ āĻā§œāĻŋā§Ÿā§‡ āϚāϞāĻž āωāϚāĻŋāϤāĨ¤

Important Precaution

  • Deep puncture wound-āĻ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āϤāĻ¤ā§āĻ¤ā§āĻŦāĻžāĻŦāϧāĻžāύ āĻ›āĻžā§œāĻž concentrated solution āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āωāϚāĻŋāϤ āύ⧟āĨ¤
  • Povidone-iodine hypersensitivity āĻĨāĻžāĻ•āϞ⧇ āϏāϤāĻ°ā§āĻ•āϤāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤
  • Thyroid disorder, significant renal impairment āĻ…āĻĨāĻŦāĻž āĻŦ⧜ āĻ•ā§āώāϤāĻ¸ā§āĻĨāĻžāύ⧇ repeated use-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻŦāĻŋāĻļ⧇āώ āϏāϤāĻ°ā§āĻ•āϤāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

Clinical Confidence in intended purpose: 0.95


8. Differential Diagnosis — āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϰ⧋āĻ—āϏāĻŽā§‚āĻš

Diagnosis āĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨ Clinical Assessment
Penetrating Soft-Tissue Injury āύāϰāĻŽ āϟāĻŋāĻ¸ā§āϝ⧁āϤ⧇ āϧāĻžāϰāĻžāϞ⧋ āĻŦāĻ¸ā§āϤ⧁āϰ āφāϘāĻžāϤ Strongly supported
Foreign Body Impaction āϟāĻŋāĻ¸ā§āϝ⧁āϰ āĻŽāĻ§ā§āϝ⧇ āĻŦāĻžāχāϰ⧇āϰ āĻŦāĻ¸ā§āϤ⧁ āφāϟāϕ⧇ āϝāĻžāĻ“ā§ŸāĻž Strongly supported
Contaminated Traumatic Wound āĻĻā§‚āώāĻŋāϤ āĻšāĻ“ā§ŸāĻžāϰ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻžāϝ⧁āĻ•ā§āϤ āφāϘāĻžāϤ Supported
Localized Wound Infection āĻ¸ā§āĻĨāĻžāĻ¨ā§€ā§Ÿ āĻ•ā§āώāϤ⧇āϰ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ Not confirmed
Soft-Tissue Abscess āύāϰāĻŽ āϟāĻŋāĻ¸ā§āϝ⧁āϤ⧇ āĻĒ⧁āρāϜ āϜāĻŽāĻž Not confirmed
Tendon Injury āĻŸā§‡āĻ¨ā§āĻĄāύ⧇āϰ āφāϘāĻžāϤ Examination required
Neurovascular Injury āĻ¸ā§āύāĻžā§Ÿā§ āĻŦāĻž āϰāĻ•ā§āϤāύāĻžāϞāĻŋāϰ āφāϘāĻžāϤ Examination required

Clinical Interpretation

āϏāĻŦāĻšā§‡ā§Ÿā§‡ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ diagnosis āĻšāϞ⧋ Foreign Body ImpactionāĨ¤

āĻļ⧁āϧ⧁ rusty material-āĻāϰ āχāϤāĻŋāĻšāĻžāϏ āĻĨāĻžāĻ•āĻžā§Ÿ āϰ⧋āĻ—ā§€āϕ⧇ Tetanus Patient āĻŦāϞāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

Tetanus prophylaxis āĻĻ⧇āĻ“ā§ŸāĻžāϰ āĻ…āĻ°ā§āĻĨ āĻšāϞ⧋ āϰ⧋āĻ— āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇āϰ āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻž āύ⧇āĻ“ā§ŸāĻž; āϰ⧋āĻ—ā§€ āχāϤāĻŋāĻŽāĻ§ā§āϝ⧇ tetanus-āĻ āφāĻ•ā§āϰāĻžāĻ¨ā§āĻ¤â€”āĻāĻŽāύ āύ⧟āĨ¤


9. My Clinical Working Assessment

āφāĻŽāĻžāϰ āĻšā§‚ā§œāĻžāĻ¨ā§āϤ āĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ

Primary Working Diagnosis

Traumatic Penetrating Soft-Tissue Injury with Foreign Body Impaction, involving Rust-Contaminated Material.

āĻŦāĻžāĻ‚āϞāĻž āϰ⧋āĻ—āύāĻŋāĻ°ā§āϪ⧟

āĻĻ⧁āĻ°ā§āϘāϟāύāĻžāϜāύāĻŋāϤ āφāϘāĻžāϤ⧇ āĻŽāϰāĻŋāϚāĻžāϝ⧁āĻ•ā§āϤ āĻŦāĻžāχāϰ⧇āϰ āϕ⧋āύ⧋ āĻŦāĻ¸ā§āϤ⧁ āύāϰāĻŽ āϟāĻŋāĻ¸ā§āϝ⧁āϰ āĻŽāĻ§ā§āϝ⧇ āĻĒā§āϰāĻŦ⧇āĻļ āĻ•āϰ⧇ āφāϟāϕ⧇ āϝāĻžāĻ“ā§ŸāĻžāϰ āχāϤāĻŋāĻšāĻžāϏāĨ¤

Pathophysiological Assessment

Foreign Body Penetration-āĻāϰ āĻ•āĻžāϰāϪ⧇ āĻ¸ā§āĻĨāĻžāĻ¨ā§€ā§Ÿ tissue injury āĻāĻŦāĻ‚ inflammatory response āϏ⧃āĻˇā§āϟāĻŋ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻ•ā§āώāϤ⧇āϰ āĻŽāĻ§ā§āϝ⧇ Foreign Body āĻ…āĻŦāĻļāĻŋāĻˇā§āϟ āĻĨāĻžāĻ•āϞ⧇:

  • Inflammation āĻĻā§€āĻ°ā§āϘāĻ¸ā§āĻĨāĻžā§Ÿā§€ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • Persistent pain āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • Secondary bacterial infection-āĻāϰ āĻā§āρāĻ•āĻŋ āĻŦāĻžā§œāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • Granulomatous reaction āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • Abscess formation āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻŦ⧇ āĻŦāĻ°ā§āϤāĻŽāĻžāύ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻāϗ⧁āϞ⧋āϰ āϕ⧋āύ⧋āϟāĻŋ āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āωāĻĒāĻ¸ā§āĻĨāĻŋāϤ āφāϛ⧇ āĻŦāϞ⧇ āĻĻāĻžāĻŦāĻŋ āĻ•āϰāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤

Clinical Confidence Assessment

Clinical Finding Confidence
History of accidental injury 0.95
History involving rusty material 0.95
Foreign Body Impaction at original presentation 0.95
Penetrating Soft-Tissue Injury 0.90
Current Retained Foreign Body Cannot determine
Active Bacterial Infection Insufficient evidence
Soft-Tissue Abscess Insufficient evidence
Clinical Tetanus No supporting evidence

Final Assessment

āĻŽā§‚āϞ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻ­āĻŋāĻ¤ā§āϤāĻŋāϤ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ Diagnosis āϝāĻĨāĻžāϝāĻĨāĻ­āĻžāĻŦ⧇ Foreign Body Impaction āĻšāĻŋāϏ⧇āĻŦ⧇ āĻŦā§āϝāĻžāĻ–ā§āϝāĻž āĻ•āϰāĻž āϝāĻžā§ŸāĨ¤

āĻāĻ–āĻžāύ⧇ āϏāĻŦāĻšā§‡ā§Ÿā§‡ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻŦāĻŋāώ⧟ āĻšāĻšā§āϛ⧇ Foreign Body Management, Wound Assessment āĻāĻŦāĻ‚ Tetanus ProphylaxisāĨ¤


10. Doctor's Diagnosis vs My Diagnosis

Comparison Treating Doctor My Assessment
Primary Diagnosis FB Impaction Penetrating Injury with FB Impaction
Injury Mechanism Accidental Accidental
Material Rusty Materials Rust-contaminated material
Infection Status Not specified Not confirmed
Foreign Body Removal Advised Assess need and confirm completion
Wound Care Debridement and Viodin Wash Irrigation, debridement and appropriate antisepsis
Tetanus Prophylaxis Vaxitet + IG noted Vaccination history-based assessment required

Are the Diagnoses Similar?

āĻšā§āϝāĻžāρāĨ¤ āĻŽā§‚āϞ āϰ⧋āĻ—āύāĻŋāĻ°ā§āĻŖā§Ÿā§‡āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ Diagnosis āĻāĻŦāĻ‚ āφāĻŽāĻžāϰ Clinical Working Diagnosis āĻāĻ•āχ āϏāĻŽāĻ¸ā§āϝāĻžāϕ⧇ āύāĻŋāĻ°ā§āĻĻ⧇āĻļ āĻ•āϰ⧇āĨ¤

āϤāĻŦ⧇ āφāĻŽāĻžāϰ Diagnosis-āĻ āφāϘāĻžāϤ⧇āϰ āϧāϰāύ, contamination risk āĻāĻŦāĻ‚ diagnostic uncertainty āφāϞāĻžāĻĻāĻž āĻ•āϰ⧇ āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤

Important Difference

āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ Diagnosis āĻšāϞ⧋:

FB Impaction

āφāĻŽāĻžāϰ āφāϰāĻ“ āĻŦāĻŋāĻ¸ā§āϤāĻžāϰāĻŋāϤ assessment āĻšāϞ⧋:

Traumatic Penetrating Soft-Tissue Injury with Foreign Body Impaction.

āϕ⧋āύ⧋ confirmed infection, abscess āĻŦāĻž tetanus āϝ⧋āĻ— āĻ•āϰāĻž āĻšā§ŸāύāĻŋāĨ¤

Estimated diagnostic agreement confidence: 0.90

āĻāχ confidence āĻāĻ•āϟāĻŋ clinical judgement, āĻĒāϰ⧀āĻ•ā§āώāĻžā§Ÿ āĻĒāϰāĻŋāĻŽāĻžāĻĒ āĻ•āϰāĻž statistical accuracy āύ⧟āĨ¤


11. Investigations — āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§Ÿ āĻĒāϰ⧀āĻ•ā§āώāĻž

Doctor’s Prescribed Investigations

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϕ⧋āύ⧋ investigation āĻ¸ā§āĻĒāĻˇā§āϟāĻ­āĻžāĻŦ⧇ āϞ⧇āĻ–āĻž āύ⧇āχāĨ¤

My Recommended Investigations

āĻĒāϰ⧀āĻ•ā§āώāĻžāϗ⧁āϞ⧋ āĻ•ā§āώāϤ⧇āϰ āĻŦāĻ°ā§āϤāĻŽāĻžāύ āĻ…āĻŦāĻ¸ā§āĻĨāĻžāϰ āĻ“āĻĒāϰ āύāĻŋāĻ°ā§āĻ­āϰ āĻ•āϰāĻŦ⧇āĨ¤

Investigation Why Needed Priority
X-ray of Affected Area Metal Foreign Body āĻļāύāĻžāĻ•ā§āϤ āĻ•āϰāĻž High if retention suspected
Soft-Tissue Ultrasound Foreign Body localization āĻ…āĻĨāĻŦāĻž collection āĻļāύāĻžāĻ•ā§āϤ āĻ•āϰāĻž Conditional
CBC āωāĻ˛ā§āϞ⧇āĻ–āϝ⧋āĻ—ā§āϝ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āϏāĻ¨ā§āĻĻ⧇āĻš āĻšāϞ⧇ Conditional
CRP āϜāϟāĻŋāϞ āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ⧇ āϏāĻšāĻžā§ŸāĻ• Conditional
Blood Glucose Diabetes āĻŦāĻž healing problem āϏāĻ¨ā§āĻĻ⧇āĻš āĻšāϞ⧇ Conditional
Pus Culture and Sensitivity Purulent āĻŦāĻž complicated infection āĻĨāĻžāĻ•āϞ⧇ Conditional
CT Scan Deep-seated FB āĻŦāĻž āϜāϟāĻŋāϞ anatomical involvement Selected cases

Why X-ray Is Important

Metal āϏāĻžāϧāĻžāϰāĻŖāϤ radiopaqueāĨ¤

āϤāĻžāχ āĻ•ā§āώāϤ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āϧāĻžāϤāĻŦ āĻŦāĻ¸ā§āϤ⧁ āφāϟāϕ⧇ āĻĨāĻžāĻ•āĻžāϰ āϏāĻ¨ā§āĻĻ⧇āĻš āĻĨāĻžāĻ•āϞ⧇ X-ray āĻāĻ•āϟāĻŋ āωāĻĒāϝ⧁āĻ•ā§āϤ initial investigationāĨ¤

Ultrasound āĻĻāĻŋā§Ÿā§‡ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻ•āĻŋāϛ⧁ Foreign Body āĻāĻŦāĻ‚ surrounding soft-tissue abnormalities āĻļāύāĻžāĻ•ā§āϤ āĻ•āϰāĻž āϝāĻžā§ŸāĨ¤


12. Bangladesh Doctors Commonly Used Drugs

āĻāχ āϧāϰāύ⧇āϰ Penetrating Injury āĻ“ Foreign Body Wound-āĻ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻ“āώ⧁āϧ⧇āϰ āωāĻĻāĻžāĻšāϰāĻŖ

āϏāĻŦ āϰ⧋āĻ—ā§€āϰ āϜāĻ¨ā§āϝ āĻāĻ•āχ āĻ“āώ⧁āϧ āĻĒā§āϰāϝ⧋āĻœā§āϝ āύ⧟āĨ¤ āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āωāĻĒāĻ¸ā§āĻĨāĻŋāϤāĻŋ, wound contamination, tetanus vaccination status āĻāĻŦāĻ‚ āϰ⧋āĻ—ā§€āϰ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻā§āρāĻ•āĻŋ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āφāϞāĻžāĻĻāĻž āĻšā§ŸāĨ¤

1. Tetanus Vaccine

Generic: Adsorbed Tetanus Vaccine** ** Brand: Vaxitet, TTvax** ** Purpose: Tetanus preventionāĨ¤

2. Human Tetanus Immunoglobulin

Generic: Human Tetanus Immunoglobulin** ** Brand: Protet-IG, Tetagam-P** ** Purpose: Dirty wound-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ vaccination history āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϞ⧇ passive protectionāĨ¤

3. Cephradine

Brand: Polycef, Lebac, Procef** ** Therapeutic Class: First Generation Cephalosporins** ** Purpose: Susceptible bacterial soft-tissue infectionāĨ¤

4. Flucloxacillin

Brand Example: A-Flox** ** Pharmacological Class: Penicillinase-resistant Penicillin** ** Purpose: āύāĻŋāĻ°ā§āĻŦāĻžāϚāĻŋāϤ staphylococcal skin and soft-tissue infectionāĨ¤

5. Naproxen Sodium + Esomeprazole

Brand: Solivo, Xenole, Dinovo** ** Purpose: Pain āĻ“ inflammation āύāĻŋ⧟āĻ¨ā§āĻ¤ā§āϰāϪ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āύāĻŋāĻ°ā§āĻŦāĻžāϚāĻŋāϤ āĻŦā§āϝāĻŦāĻšāĻžāϰ; Esomeprazole NSAID-related gastric ulcer risk āĻ•āĻŽāĻžāϤ⧇ āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āϰ⧇āĨ¤

6. Paracetamol

Brand: Napa 500 mg** ** Generic: Paracetamol** ** Purpose: Mild-to-moderate pain āĻ…āĻĨāĻŦāĻž fever managementāĨ¤

MedEx Price: ā§ŗ1.20 per tablet; ā§ŗ12.00 per 10-tablet stripāĨ¤

MedEx Link: Napa 500 mg — MedEx

7. Povidone Iodine

Brand: Viodin, Betadine** ** Pharmacological Class: Topical Antiseptic** ** Purpose: āωāĻĒāϝ⧁āĻ•ā§āϤ wound antisepsisāĨ¤

Clinical Caution

Antibiotic-āϗ⧁āϞ⧋ āĻāĻ•āϏāĻ™ā§āϗ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻžāϰ āϤāĻžāϞāĻŋāĻ•āĻž āύ⧟āĨ¤ uncomplicated wound-āĻ antibiotic āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āύāĻžāĻ“ āĻšāϤ⧇ āĻĒāĻžāϰ⧇; contaminated āĻ…āĻĨāĻŦāĻž high-risk wound-āĻ antibiotic prophylaxis āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āϝāĻžā§ŸāĨ¤


13. Doctor's Actionable Management Plan

Step 1 — Assess the Wound

āĻ•ā§āώāϤ⧇āϰ āĻ¸ā§āĻĨāĻžāύ, āĻ—āĻ­ā§€āϰāϤāĻž, contamination, tenderness āĻāĻŦāĻ‚ neurovascular status āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 2 — Investigate Retained Foreign Body

Foreign Body āĻ…āĻŦāĻļāĻŋāĻˇā§āϟ āĻĨāĻžāĻ•āĻžāϰ āϏāĻ¨ā§āĻĻ⧇āĻš āĻĨāĻžāĻ•āϞ⧇ X-ray āĻ…āĻĨāĻŦāĻž āωāĻĒāϝ⧁āĻ•ā§āϤ imaging āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 3 — Foreign Body Removal

Foreign Body āĻĨāĻžāĻ•āϞ⧇ āĻ…āĻŦāĻ¸ā§āĻĨāĻžāύ āĻāĻŦāĻ‚ anatomical risk āĻ…āύ⧁āϝāĻžā§Ÿā§€ removal-āĻāϰ āϏāĻŋāĻĻā§āϧāĻžāĻ¨ā§āϤ āύāĻŋāϤ⧇ āĻšāĻŦ⧇āĨ¤

Deeply embedded object, tendon, nerve āĻŦāĻž blood vessel-āĻāϰ āĻ•āĻžāĻ›āĻžāĻ•āĻžāĻ›āĻŋ āĻĨāĻžāĻ•āϞ⧇ specialist removal āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Step 4 — Wound Irrigation and Debridement

āĻ•ā§āώāϤ āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇ āĻāĻŦāĻ‚ devitalized tissue āĻĨāĻžāĻ•āϞ⧇ āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĻŽāϤ⧋ debridement āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Normal saline irrigation āϏāĻžāϧāĻžāϰāĻŖāϤ āωāĻĒāϝ⧁āĻ•ā§āϤāĨ¤

Viodin āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĻŽāϤ⧋ surrounding skin antisepsis-āĻāϰ āϜāĻ¨ā§āϝ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Step 5 — Review Tetanus Protection

Vaccination history āϝāĻžāϚāĻžāχ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϞ⧇ guideline āĻ…āύ⧁āϝāĻžā§Ÿā§€ vaccine āĻāĻŦāĻ‚ Human TIG āĻĻāĻŋāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 6 — Assess Antibiotic Requirement

Infection āĻ…āĻĨāĻŦāĻž high-risk wound-āĻāϰ clinical evidence āĻĨāĻžāĻ•āϞ⧇ appropriate antibiotic āύāĻŋāĻ°ā§āĻŦāĻžāϚāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

āĻļ⧁āϧ⧁ āϟāĻŋāĻŸā§‡āύāĻžāϏ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ antibiotic āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āωāϚāĻŋāϤ āύ⧟āĨ¤

Step 7 — Pain Management

āĻŦā§āϝāĻĨāĻžāϰ āϤ⧀āĻŦā§āϰāϤāĻž āĻ“ āϰ⧋āĻ—ā§€āϰ contraindication āĻ…āύ⧁āϝāĻžā§Ÿā§€ analgesic āύāĻŋāĻ°ā§āĻŦāĻžāϚāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Solivo āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāϞ⧇ NSAID-related gastrointestinal, renal āĻāĻŦāĻ‚ bleeding risks āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 8 — Follow-up

Foreign Body Removal āϏāĻŽā§āĻĒāĻ¨ā§āύ āĻšā§Ÿā§‡āϛ⧇ āĻ•āĻŋ āύāĻž āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Persistent pain, swelling, discharge, fever āĻŦāĻž impaired movement āĻĨāĻžāĻ•āϞ⧇ āĻĒ⧁āύāĻ°ā§āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

Important: āĻāχ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύāϟāĻŋ ⧍ā§Ļā§¨ā§Š āϏāĻžāϞ⧇āϰ āĻšāϞ⧇ āωāĻĒāϰ⧋āĻ•ā§āϤ plan āĻĒ⧁āϰ⧋āύ⧋ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āϘāϟāύāĻžāϰ āĻŦāĻŋāĻļā§āϞ⧇āώāĻŖ āĻšāĻŋāϏ⧇āĻŦ⧇ āĻĒā§āϰāϝ⧋āĻœā§āϝāĨ¤ ⧍ā§Ļ⧍ā§Ŧ āϏāĻžāϞ⧇ āϰ⧋āĻ—ā§€āϰ āĻŦāĻ°ā§āϤāĻŽāĻžāύ āĻ…āĻŦāĻ¸ā§āĻĨāĻž āύāĻž āĻœā§‡āύ⧇ āύāϤ⧁āύ āĻ•āϰ⧇ āĻāĻ•āχ āĻ“āώ⧁āϧ āĻļ⧁āϰ⧁ āĻ•āϰāĻž āωāϚāĻŋāϤ āύ⧟āĨ¤


14. Referral — āϕ⧋āύ āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžā§‡āϰ āĻ•āĻžāϛ⧇ āĻĒāĻžāĻ āĻžāĻŦ⧇āύ?

Primary Referral

General Surgeon — āĻœā§‡āύāĻžāϰ⧇āϞ āϏāĻžāĻ°ā§āϜāύ

Reason for Referral

  • Foreign Body Evaluation
  • Surgical Exploration
  • Foreign Body Removal
  • Wound Debridement
  • Assessment of Complications

Other Specialties

Orthopaedic Surgeon: āĻšāĻžā§œ, āĻœā§Ÿā§‡āĻ¨ā§āϟ āĻŦāĻž āĻ—āĻ­ā§€āϰ musculoskeletal injury āĻĨāĻžāĻ•āϞ⧇āĨ¤

Hand Surgeon / Plastic Surgeon: āĻšāĻžāϤ⧇āϰ āĻ—āĻ­ā§€āϰ āĻ•ā§āώāϤ, tendon injury, nerve injury āĻ…āĻĨāĻŦāĻž āϜāϟāĻŋāϞ soft-tissue damage āĻĨāĻžāĻ•āϞ⧇āĨ¤

Suggested Referral Note

Referred to General Surgery for evaluation of penetrating soft-tissue injury with a history of foreign-body impaction, to assess for any retained foreign body and determine the need for surgical exploration, removal and wound debridement.

āĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨ: āύāϰāĻŽ āϟāĻŋāĻ¸ā§āϝ⧁āϤ⧇ āĻĻ⧁āĻ°ā§āϘāϟāύāĻžāϜāύāĻŋāϤ āφāϘāĻžāϤ āĻ“ āĻŦāĻžāχāϰ⧇āϰ āĻŦāĻ¸ā§āϤ⧁ āφāϟāϕ⧇ āϝāĻžāĻ“ā§ŸāĻžāϰ āχāϤāĻŋāĻšāĻžāϏ āĻĨāĻžāĻ•āĻžā§Ÿ Foreign Body āĻ…āĻŦāĻļāĻŋāĻˇā§āϟ āφāϛ⧇ āĻ•āĻŋ āύāĻž āĻāĻŦāĻ‚ surgical management āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ•āĻŋ āύāĻž, āϤāĻž āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ⧇āϰ āϜāĻ¨ā§āϝ āĻœā§‡āύāĻžāϰ⧇āϞ āϏāĻžāĻ°ā§āϜāĻžāϰāĻŋ āĻŦāĻŋāĻ­āĻžāϗ⧇ āϰ⧇āĻĢāĻžāϰ āĻ•āϰāĻž āĻšāϞ⧋āĨ¤


15. Final Clinical Diagnosis — Prescription-āĻ āϕ⧀ āϞāĻŋāĻ–āĻŦ⧇āύ?

Doctor’s Diagnosis

Dx: FB Impaction

āĻŦāĻžāĻ‚āϞāĻž: āĻļāϰ⧀āϰ⧇āϰ āϟāĻŋāĻ¸ā§āϝ⧁āϰ āĻŽāĻ§ā§āϝ⧇ āĻŦāĻžāχāϰ⧇āϰ āĻŦāĻ¸ā§āϤ⧁ āφāϟāϕ⧇ āϝāĻžāĻ“ā§ŸāĻžāĨ¤

My Clinical Working Diagnosis

Dx: Traumatic Penetrating Soft-Tissue Injury with Foreign Body Impaction (Rust-Contaminated Material).

āĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨ

āĻĻ⧁āĻ°ā§āϘāϟāύāĻžāϜāύāĻŋāϤ āφāϘāĻžāϤ⧇ āĻŽāϰāĻŋāϚāĻžāϝ⧁āĻ•ā§āϤ āĻŦāĻžāχāϰ⧇āϰ āĻŦāĻ¸ā§āϤ⧁ āĻļāϰ⧀āϰ⧇āϰ āύāϰāĻŽ āϟāĻŋāĻ¸ā§āϝ⧁āϤ⧇ āĻĒā§āϰāĻŦ⧇āĻļ āĻ•āϰ⧇ āφāϟāϕ⧇ āϝāĻžāĻ“ā§ŸāĻžāĨ¤

Short Clinical Diagnosis

Dx: Penetrating Soft-Tissue Injury with FB Impaction.

āĻāϟāĻŋ āĻŽā§‚āϞ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āϤāĻĨā§āϝ⧇āϰ āϏāĻ™ā§āϗ⧇ āϏāĻžāĻŽāĻžā§āϜāĻ¸ā§āϝāĻĒā§‚āĻ°ā§āĻŖāĨ¤

Important Diagnostic Clarification

āϝāĻĻāĻŋ āĻŦāĻ°ā§āϤāĻŽāĻžāύ āĻĒāϰ⧀āĻ•ā§āώāĻžā§Ÿ Foreign Body āĻ…āĻŦāĻļāĻŋāĻˇā§āϟ āĻĨāĻžāĻ•āĻžāϰ āĻĒā§āϰāĻŽāĻžāĻŖ āύāĻž āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§Ÿ, āϤāĻžāĻšāϞ⧇ āĻāĻ–āύāĻ•āĻžāϰ Diagnosis āĻšāĻŋāϏ⧇āĻŦ⧇ Retained Foreign Body āϞ⧇āĻ–āĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

āϝāĻĻāĻŋ removal āχāϤāĻŋāĻŽāĻ§ā§āϝ⧇ āϏāĻŽā§āĻĒāĻ¨ā§āύ āĻšā§Ÿā§‡ āĻĨāĻžāϕ⧇, āϤāĻžāĻšāϞ⧇ āύāĻĨāĻŋāϭ⧁āĻ•ā§āϤ āϤāĻĨā§āϝ āĻ…āύ⧁āϝāĻžā§Ÿā§€ History of Foreign Body Impaction, S/P Foreign Body Removal āϞ⧇āĻ–āĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϝāĻĻāĻŋ imaging āĻŦāĻž examination-āĻ Foreign Body āĻ…āĻŦāĻļāĻŋāĻˇā§āϟ āĻĨāĻžāĻ•āĻžāϰ āĻĒā§āϰāĻŽāĻžāĻŖ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§Ÿ, āϤāĻŦ⧇āχ Retained Foreign Body āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āϞ⧇āĻ–āĻž āϝāĻžāĻŦ⧇āĨ¤


16. Overview / Final Summary

Clinical Parameter Final Assessment
Chief Complaint Accidental Impaction of Rusty Materials
Doctor’s Diagnosis Foreign Body Impaction
My Working Diagnosis Penetrating Soft-Tissue Injury with Foreign Body Impaction
Injury Type Traumatic Penetrating Injury
Tetanus Risk Wound characteristics and vaccination history need assessment
Antibiotic Polycef 500 mg
Pain Medicine Solivo 500 mg + 20 mg
Vaccine Vaxitet
Passive Immunization IG mentioned; preparation unconfirmed
Wound Antiseptic Viodin Solution
Procedural Advice Excision, Drainage, FB Removal and Debridement
Investigation None explicitly prescribed
Primary Referral General Surgeon

Final Clinical Opinion

āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ Diagnosis āĻāĻŦāĻ‚ āφāĻŽāĻžāϰ Clinical Working Assessment-āĻāϰ āĻŽāĻ§ā§āϝ⧇ āĻŽā§ŒāϞāĻŋāĻ• āϕ⧋āύ⧋ āĻŦāĻŋāϰ⧋āϧ āύ⧇āχāĨ¤

āĻāχ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻĒā§āϰāϧāĻžāύ āϏāĻŽāĻ¸ā§āϝāĻž āĻšāϞ⧋ Foreign Body Impaction following accidental penetrating injuryāĨ¤

āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ prescribed management-āĻāϰ āĻŽā§‚āϞ āωāĻĻā§āĻĻ⧇āĻļā§āϝ āĻ›āĻŋāϞ Foreign Body āĻ…āĻĒāϏāĻžāϰāĻŖ, wound management, tetanus prevention āĻāĻŦāĻ‚ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ bacterial complications āύāĻŋ⧟āĻ¨ā§āĻ¤ā§āϰāĻŖāĨ¤

āϤāĻŦ⧇ āĻ•ā§āώāϤ⧇āϰ āĻŦāĻ°ā§āϤāĻŽāĻžāύ āĻ…āĻŦāĻ¸ā§āĻĨāĻž āĻ“ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āϏāĻŽā§āĻĒāĻ¨ā§āύ āĻšāĻ“ā§ŸāĻžāϰ āϤāĻĨā§āϝ āĻ›āĻžā§œāĻž ongoing infection āĻŦāĻž retained foreign body āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϏāĻŽā§āĻ­āĻŦ āύ⧟āĨ¤


17. Reference List

A. Standard Medical Textbooks

1. Bailey & Love’s Short Practice of Surgery. 27th Edition. CRC Press; 2018. Relevant topics: Wound Management, Surgical Infection and Surgical Trauma.

2. Harrison’s Principles of Internal Medicine. 22nd Edition. McGraw Hill; 2025. Relevant topic: Tetanus.

3. Robbins & Cotran Pathologic Basis of Disease. 10th Edition. Elsevier; 2020. Relevant topics: Inflammation, Tissue Injury and Wound Healing.

4. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. Relevant sections: NSAIDs, Beta-lactam Antibiotics and Antiseptics.

B. Clinical Guidelines

5. CDC. Clinical Guidance for Wound Management to Prevent Tetanus. Updated 8 September 2026.

CDC Tetanus Wound Management Guidelines

6. WSES/AcEMC. Management of Traumatic Wounds in the Emergency Department. 2016.

WSES Traumatic Wound Management

C. Peer-Reviewed Journals with DOI

7. Prevaldi C, Paolillo C, Locatelli C, et al. Management of traumatic wounds in the Emergency Department: position paper from AcEMC and WSES. World Journal of Emergency Surgery. 2016;11:30.

DOI: 10.1186/s13017-016-0084-3

8. Rupert J, Honeycutt JD, Odom MR. Foreign Bodies in the Skin: Evaluation and Management. American Family Physician. 2020;101(12):740–747.

AAFP Foreign Body Evaluation and Management

D. MedEx Bangladesh — Verified Brand References

Drug MedEx Reference
Vaxitet Vaxitet 40 IU/0.5 ml
Human Tetanus Immunoglobulin Protet-IG 250 IU/ml
Polycef Polycef 500 mg
Solivo Solivo 500 mg + 20 mg
Viodin Viodin 10% Solution

FINAL PRESCRIPTION Dx:

Traumatic Penetrating Soft-Tissue Injury with Foreign Body Impaction (Rust-Contaminated Material).

āĻŦāĻžāĻ‚āϞāĻž: āĻĻ⧁āĻ°ā§āϘāϟāύāĻžāϜāύāĻŋāϤ āφāϘāĻžāϤ⧇ āĻŽāϰāĻŋāϚāĻžāϝ⧁āĻ•ā§āϤ āĻŦāĻžāχāϰ⧇āϰ āĻŦāĻ¸ā§āϤ⧁ āύāϰāĻŽ āϟāĻŋāĻ¸ā§āϝ⧁āϤ⧇ āĻĒā§āϰāĻŦ⧇āĻļ āĻ•āϰ⧇ āφāϟāϕ⧇ āϝāĻžāĻ“ā§ŸāĻžāĨ¤

Author: Md. Rafiqul Islam Lipu

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top